ALK-ABELLÓ A/S: Financial statements 2014
CVR: 63717916
Source: annual report 2014, Danish Business Authority
01/01/2014 – 31/12/2014
ALK-ABELLÓ A/S (CVR 63717916) has filed annual accounts for 2014. In 2014, the company reported revenue of DKK 2,433,000,000 and a net result of DKK 181,000,000. The profit margin was 7.4%. Equity in the 2014 report amounted to DKK 2,354,000,000. The solvency ratio was 68.9%.
- Revenue
- DKK 2,433,000,000
- Gross Profit
- DKK 1,697,000,000
- Profit/Loss
- DKK 181,000,000
- Equity
- DKK 2,354,000,000
- Total Assets
- DKK 3,419,000,000
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2014
As of October 1, 2014, Helle Skov Wagner is registered as director of ALK-ABELLÓ A/S.
ALK-ABELLÓ A/S has published its interim report for the period January 1, 2014 to June 30, 2014.
ALK-ABELLÓ A/S has published its interim report for the period January 1, 2014 to March 31, 2014.
As of April 28, 2014, Flemming Steen Jensen has stepped down as director of ALK-ABELLÓ A/S.
ALK-ABELLÓ A/S has published its annual report for 2013.
As of March 12, 2014, Lene Skole-Sørensen has joined the board of directors of ALK-ABELLÓ A/S.
As of March 12, 2014, Jes Christian Wibroe Østergaard has left the board of directors of ALK-ABELLÓ A/S.
About ALK-ABELLÓ A/S
ALK-ABELLÓ A/S is a Danish company of the type Aktieselskab based in Hørsholm, founded in 1961. The company is registered under the industry Fremstilling af farmaceutiske præparater. The company was previously named ALK A/S and ALLERGOLOGISK LABORATORIUM A/S. The management consists of Peter Halling and Claus Steensen Sølje. The board consists of Anders Hedegaard (chair), Lene Skole-Sørensen, Alan Main and Bertil Erik Lindmark. The company is owned by LUNDBECKFOND INVEST A/S. The company has 1,017 employees (2026). In 2025, the company reported revenue of DKK 6,312,000,000 and a net result of DKK 1,197,000,000 compared with DKK 815,000,000 the year before. Equity in the 2025 report amounted to DKK 6,445,000,000.